Smith P[au] - Search Results

Year	Number of Results
1868	1
1869	2
1870	3
1871	1
1872	2
1873	1
1874	1
1875	1
1876	1
1883	1
1888	3
1889	5
1892	1
1895	1
1897	1
1898	1
1901	1
1903	1
1906	2
1913	1
1915	2
1916	1
1917	2
1918	2
1919	2
1921	2
1922	1
1923	1
1924	1
1927	2
1930	1
1931	2
1932	1
1933	1
1934	1
1936	1
1938	2
1939	2
1940	2
1941	4
1942	4
1943	1
1944	2
1945	3
1946	22
1947	9
1948	13
1949	13
1950	22
1951	24
1952	21
1953	20
1954	26
1955	18
1956	13
1957	21
1958	17
1959	19
1960	14
1961	20
1962	19
1963	18
1964	20
1965	26
1966	36
1967	36
1968	41
1969	55
1970	39
1971	42
1972	60
1973	50
1974	78
1975	63
1976	87
1977	88
1978	104
1979	88
1980	108
1981	110
1982	143
1983	142
1984	130
1985	135
1986	171
1987	149
1988	158
1989	138
1990	194
1991	173
1992	179
1993	174
1994	176
1995	189
1996	222
1997	184
1998	215
1999	229
2000	243
2001	226
2002	216
2003	248
2004	292
2005	305
2006	314
2007	319
2008	301
2009	326
2010	341
2011	404
2012	428
2013	427
2014	430
2015	414
2016	463
2017	444
2018	445
2019	429
2020	473
2021	221

1

Human Challenge Studies to Accelerate Coronavirus Vaccine Licensure.

Eyal N, Lipsitch M, Smith PG. Eyal N, et al. Among authors: smith pg. J Infect Dis. 2020 May 11;221(11):1752-1756. doi: 10.1093/infdis/jiaa152. J Infect Dis. 2020. PMID: 32232474 Free PMC article.

2

Inhibition of cytokine signaling by ruxolitinib and implications for COVID-19 treatment.

Yeleswaram S, Smith P, Burn T, Covington M, Juvekar A, Li Y, Squier P, Langmuir P. Yeleswaram S, et al. Among authors: smith p. Clin Immunol. 2020 Sep;218:108517. doi: 10.1016/j.clim.2020.108517. Epub 2020 Jun 23. Clin Immunol. 2020. PMID: 32585295 Free PMC article. Review.

3

Management of Established Status Epilepticus.

Smith PE. Smith PE. N Engl J Med. 2019 Nov 28;381(22):2171-2172. doi: 10.1056/NEJMe1913775. N Engl J Med. 2019. PMID: 31774965 No abstract available.

4

MEK inhibition reprograms CD8⁺ T lymphocytes into memory stem cells with potent antitumor effects.

Verma V, Jafarzadeh N, Boi S, Kundu S, Jiang Z, Fan Y, Lopez J, Nandre R, Zeng P, Alolaqi F, Ahmad S, Gaur P, Barry ST, Valge-Archer VE, Smith PD, Banchereau J, Mkrtichyan M, Youngblood B, Rodriguez PC, Gupta S, Khleif SN. Verma V, et al. Among authors: smith pd. Nat Immunol. 2021 Jan;22(1):53-66. doi: 10.1038/s41590-020-00818-9. Epub 2020 Nov 23. Nat Immunol. 2021. PMID: 33230330

5

British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic.

Kennedy NA, Jones GR, Lamb CA, Appleby R, Arnott I, Beattie RM, Bloom S, Brooks AJ, Cooney R, Dart RJ, Edwards C, Fraser A, Gaya DR, Ghosh S, Greveson K, Hansen R, Hart A, Hawthorne AB, Hayee B, Limdi JK, Murray CD, Parkes GC, Parkes M, Patel K, Pollok RC, Powell N, Probert CS, Raine T, Sebastian S, Selinger C, Smith PJ, Stansfield C, Younge L, Lindsay JO, Irving PM, Lees CW. Kennedy NA, et al. Among authors: smith pj. Gut. 2020 Jun;69(6):984-990. doi: 10.1136/gutjnl-2020-321244. Epub 2020 Apr 17. Gut. 2020. PMID: 32303607 Free PMC article.

6

Elevated rates of autism, other neurodevelopmental and psychiatric diagnoses, and autistic traits in transgender and gender-diverse individuals.

Warrier V, Greenberg DM, Weir E, Buckingham C, Smith P, Lai MC, Allison C, Baron-Cohen S. Warrier V, et al. Among authors: smith p. Nat Commun. 2020 Aug 7;11(1):3959. doi: 10.1038/s41467-020-17794-1. Nat Commun. 2020. PMID: 32770077 Free PMC article.

7

Drug Sensitivity and Allele Specificity of First-Line Osimertinib Resistance EGFR Mutations.

Starrett JH, Guernet AA, Cuomo ME, Poels KE, van Alderwerelt van Rosenburgh IK, Nagelberg A, Farnsworth D, Price KS, Khan H, Ashtekar KD, Gaefele M, Ayeni D, Stewart TF, Kuhlmann A, Kaech SM, Unni AM, Homer R, Lockwood WW, Michor F, Goldberg SB, Lemmon MA, Smith PD, Cross DAE, Politi K. Starrett JH, et al. Among authors: smith pd. Cancer Res. 2020 May 15;80(10):2017-2030. doi: 10.1158/0008-5472.CAN-19-3819. Epub 2020 Mar 19. Cancer Res. 2020. PMID: 32193290 Free PMC article.

8

The Genomic Landscape of Intrinsic and Acquired Resistance to Cyclin-Dependent Kinase 4/6 Inhibitors in Patients with Hormone Receptor-Positive Metastatic Breast Cancer.

Wander SA, Cohen O, Gong X, Johnson GN, Buendia-Buendia JE, Lloyd MR, Kim D, Luo F, Mao P, Helvie K, Kowalski KJ, Nayar U, Waks AG, Parsons SH, Martinez R, Litchfield LM, Ye XS, Yu C, Jansen VM, Stille JR, Smith PS, Oakley GJ, Chu QS, Batist G, Hughes ME, Kremer JD, Garraway LA, Winer EP, Tolaney SM, Lin NU, Buchanan SG, Wagle N. Wander SA, et al. Among authors: smith ps. Cancer Discov. 2020 Aug;10(8):1174-1193. doi: 10.1158/2159-8290.CD-19-1390. Epub 2020 May 13. Cancer Discov. 2020. PMID: 32404308

9

Optimizing COVID-19 Candidate Therapeutics: Thinking Without Borders.

Rayner CR, Smith PF, Hershberger K, Wesche D. Rayner CR, et al. Among authors: smith pf. Clin Transl Sci. 2020 Sep;13(5):830-834. doi: 10.1111/cts.12790. Epub 2020 May 2. Clin Transl Sci. 2020. PMID: 32212378 Free PMC article. No abstract available.

10

EUFOREA treatment algorithm for allergic rhinitis.

Hellings PW, Scadding G, Bachert C, Bjermer L, Canonica GW, Cardell LO, Carney AS, Constantinidis J, Deneyer L, Diamant Z, Durham S, Gevaert P, Harvey R, Hopkins C, Kjeldsen A, Klimek L, Lund VJ, Price D, Rimmer J, Ryan D, Roberts G, Sahlstrand-Johnson P, Salmi S, Samji M, Scadding G, Smith P, Steinsvik A, Wagenmann M, Seys S, Wahn U, Fokkens WJ. Hellings PW, et al. Among authors: smith p. Rhinology. 2020 Dec 1;58(6):618-622. doi: 10.4193/Rhin20.246. Rhinology. 2020. PMID: 32991658 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results